Literature DB >> 18319140

Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.

Patrick J Twomey1, Adie Viljoen, Timothy M Reynolds, Anthony S Wierzbicki.   

Abstract

BACKGROUND: Copper is an essential nutrient but is toxic when the free form is in excess. Wilson's disease (WD) is an autosomal recessive disorder of copper excess. Its diagnosis is a challenge, especially in the absence of obvious neurological changes, or Kayser-Fleischer rings. Non-ceruloplasmin-bound copper is a calculated parameter devised for the investigation of patients who potentially have WD.
METHODS: We compared non-ceruloplasmin-bound copper from three different laboratories. We retrospectively reviewed paired ceruloplasmin and copper data and calculated non-ceruloplasmin-bound copper. Comparative statistics, linear regression, chi-square test and graphical techniques were employed to compare the data.
RESULTS: All three assays had negative results for over 20% of the non-ceruloplasmin-bound copper concentrations; this was not significantly different. However, there were statistically significant differences for the 97.5th percentile. When plotted against the ceruloplasmin and copper concentrations, significant differences existed for both the visual and linear regression data between the three different laboratories.
CONCLUSIONS: Non-ceruloplasmin-bound copper cut-offs may not be transferable between laboratories. Each laboratory should derive its own cut-offs for the 97.5th percentile, as there are differences due to assays, populations or both.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319140     DOI: 10.1016/j.jtemb.2007.11.001

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  7 in total

Review 1.  Current anti-copper therapies in management of Wilson disease.

Authors:  Isabelle Mohr; Karl Heinz Weiss
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  New tools for Wilson's disease diagnosis: exchangeable copper fraction.

Authors:  France Woimant; Nouzha Djebrani-Oussedik; Aurélia Poujois
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Apoceruloplasmin: Abundance, Detection, Formation, and Metabolism.

Authors:  Maria C Linder
Journal:  Biomedicines       Date:  2021-02-25

Review 4.  Chelation therapy in liver diseases of childhood: Current status and response.

Authors:  Jayendra Seetharaman; Moinak Sen Sarma
Journal:  World J Hepatol       Date:  2021-11-27

5.  Secretion and uptake of copper via a small copper carrier in blood fluid.

Authors:  B D Gioilli; T Z Kidane; H Fieten; M Tellez; M Dalphin; A Nguyen; K Nguyen; M C Linder
Journal:  Metallomics       Date:  2022-03-25       Impact factor: 4.526

6.  Speciation of Serum Copper and Zinc-Binding High- and Low-Molecular Mass Ligands in Dairy Cows Using HPLC-ICP-MS Technique.

Authors:  Sergey A Miroshnikov; Svetlana V Notova; Margarita G Skalnaya; Elena A Sizova; Olga V Marshinskaia; Tatiana V Kazakova; Anatoly V Skalny; Bernhard Michalke; Olga P Ajsuvakova; Alexey A Tinkov
Journal:  Biol Trace Elem Res       Date:  2021-03-15       Impact factor: 3.738

7.  Effects of Dietary Glucose and Fructose on Copper, Iron, and Zinc Metabolism Parameters in Humans.

Authors:  Nathaniel H O Harder; Bettina Hieronimus; Kimber L Stanhope; Noreene M Shibata; Vivien Lee; Marinelle V Nunez; Nancy L Keim; Andrew Bremer; Peter J Havel; Marie C Heffern; Valentina Medici
Journal:  Nutrients       Date:  2020-08-25       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.